In silico study of asiatic acid interaction with Inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2)

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 5, Issue SUPPL.1, 2013, Pages 204-207

  Musfiroh, Ida ^a,b   Nursamsiar, ^a   Muhtadi, Ahmad ^b   Kartasasmita, Rahmana E ^a   Tjahjono, Daryono H ^a   Slamet Ibrahim, S ^a  

^a BANDUNG INSTITUTE OF TECHNOLOGY   (Indonesia)

^b PADJADJARAN UNIVERSITY   (Indonesia)

Author keywords

Asiatic acid; COX 2; In silico study; iNOS

Indexed keywords

AMINO ACID; ASIATIC ACID; CYCLOOXYGENASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; NAPROXEN;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BINDING AFFINITY; COMPUTER MODEL; DISULFIDE BOND; DRUG RECEPTOR BINDING; ENZYME ACTIVE SITE; HYDROGEN BOND; INFLAMMATION; MOLECULAR DOCKING; PROTEIN INTERACTION; PROTEIN STRUCTURE; SIMULATION; VALIDATION PROCESS;

EID: 84875453924     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Jeong BS, Asiatic Acid Derivatives for New Wound Healing Agent, Archives of Pharmacal Research, 2006; 29, No. 7: 556-562.
2. S. S Huang, C. S Chiu, H. J Chen, W. C Hou, M. J Sheu, Y. C Lin, P. H Shie, G. J Huang, Antinociceptive Activities and the Mechanisms of Anti-Inflammatory of Asiatic Acid in Mice, Evidence-Based Complementary and Alternative Medicine, Volume 2011; Article ID 895857, 10 pages.
3. K. J Yun, Y. J Kim, J. B Kim, K. W Lee, S. Y Jeong, H. J Park, H. J Jung et al., Inhibition of LPS-induced NO and PGE2 production by asiatic acid via NF-κB inactivation in RAW 264. 7 macrophages: Possible involvement of the IKK and MAPK pathways, Int. Immunopharmacol, 2008; 8: 431-441.
4. Yadav VR, Prasad S, Sung B, Kannappan R, Aggarwal BB, Review Targeting Inflammatory Pathways by Triterpenoids for Prevention and Treatment of Cancer, Toxin, 2011; 2: 2428-2466.
5. Suh N, Honda T, Finlay HJ, Novel Triterpenoids Suppress Inducible Nitric Oxide Synthase (iNOS) and Inducible Cyclooxygenase (COX-2) in Mouse Macrophages, Cancer Res, 1998; 58: 717-723.
6. Calixto JB, Otuki MF, Santos ARS, Anti-Inflammatory Compounds of Plant Origin. Part I. Acion on Arachidonic Acid Pathway, Nitric Oxide and Nuclear Faktor kB (NF-kB), Planta medica, 2003; 69: 973-983.
7. Yang EJ, Yim EY., Song G, Kim Gi-Ok, Hyun CG, Inhibition of nitric oxide production in lipopolysaccharide-activated RAW 267. 4 macrophages by Jeju plant extracts, Interdisc Toxicol, 2009; 2(4): 245-249.
8. Blobaum AL. and Lawrence JM, Structural and Functional Basis of Cyclooxygenase Inhibition, J. Med. Chem, 2007; 50(7), 1425-1441.
9. Smith RM., DeWitt DI., Garavito RM., Cyclooxgenases: structural, cellular and molecular biology, Ann Rev Biochem, 2000; 69: 145-182.
10. Liang YC, Huang YT, Tsai SH, Shiau SYL., Chen CF., Lin JK., Supression of Inducible cyclooxgenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages, Carcinogenesis, 1999; 20: 1945-1952.
11. lck Protein Tyrosine Kinase Using PLS, Int J Pharm Pharm Sci, 2011; 3(4), 44-52.
12. Goodsell DS. & Olson AJ, Automated Docking of Substrates to Proteins by Simulated Annealing, Proteins: Str. Func. Genet. 1990(8): 195-202.
13. Kroemer RT, Molecular modelling probes: docking and scoring. Biochemical Society Transactions, 2003; 31: 980-984.
14. Schaeffer L., The Practice of Medicinal Chemistry, Thrid edition, 2008 (26), Elsevier. Ltd. p: 464-471
15. Li H, Raman C. S, Glaser C. B, Blasko E, Young T. A, Parkinson J. F, Whitlow M, Poulos T. L., Crystal structures of zinc-free and-bound heme domain of human inducible nitric-oxide synthase. Implications for dimer stability and comparison with endothelial nitric-oxide synthase, J Biol Chem. 1999 Jul 23; 274(30): 21276-84.
16. Duggan KC, Walters MJ, Musse J, Harp JM et al., Molecular Basis for Cyclooxygenase Inhibition by the Non-steroidal Anti-inflammatory Drug Naproxen, J. Biol Chem. 2010; 285(45): 34950-34959.
17. Morris, G. M and M. Lim-Wilby, Molecular Docking, Methods in Molecular Modelling in Molecular Biology, In Molecular Modelling of Protein, Kukol, A. (Ed), Human Press, Totowa, New Jersey, pp: 365-382.
18. D'Mello P, Gadhwal MK, Joshi U, Shetgiri P, Modelling of COX-2 Inhibitory Activity of Flavonoids, Int J Pharm Pharm Sci, 2011; 3 (4): 33-40.
19. Llorens O, Perez J, Palomer A and Mauleon D: Differential binding mode of Diverse cyclooxygenase inhibitors, Journal of Molecular Graphics and Modelling, 2002; 20: 359-371.
20. Kurumbail RG, Stevens AM, Gierse JK, McDonald JJ, Stegeman RA, Pak JY, Gildehaus D, Miyashiro JM, Penning TD, Seibert K, Isakson PC, Stallings WC: Structural Basis for Selective Inhibition of cyclooxygenase 2 by antiinflammatory agents, Nature, 1996; 384: 644.
21. Francis, S. M., A Mittal, M. Sharma and P. V. Bharatam, Design of Benzene-1, 2-diamines as selective inducible nitric oxide synthase inhibitors: A combined de novo design and docking analysis, J. Mol. Model., 14: 215-224.